Hanming, H., & Hanzhi, Z. Breaking the 'Undruggable' Barrier: Nanoparticle-Based Combination Therapy Utilizing Sotorasib and PD-L1 Inhibitor for Treating Non-Small Cell Lung Cancer Patients with KRASG12C Mutations. EDP Sciences.
Chicago Style (17th ed.) CitationHanming, Hao, and Zhang Hanzhi. Breaking the 'Undruggable' Barrier: Nanoparticle-Based Combination Therapy Utilizing Sotorasib and PD-L1 Inhibitor for Treating Non-Small Cell Lung Cancer Patients with KRASG12C Mutations. EDP Sciences.
MLA (9th ed.) CitationHanming, Hao, and Zhang Hanzhi. Breaking the 'Undruggable' Barrier: Nanoparticle-Based Combination Therapy Utilizing Sotorasib and PD-L1 Inhibitor for Treating Non-Small Cell Lung Cancer Patients with KRASG12C Mutations. EDP Sciences.
Warning: These citations may not always be 100% accurate.